Short answer · Medically reviewed summary · Last updated: 2026-05-08
Megalencephaly-Capillary Malformation-Polymicrogyria Syndrome (MCAP) is most commonly referred to by its acronym, MCAP, or as Megalencephaly-Capillary Malformation Syndrome. Due to its complex clinical presentation, it was historically categorized under various names before the genetic cause, specifically mutations in the PIK3CA gene, was identified. What are the historical and alternative names for MCAP? Before the current, more precise nomenclature was adopted, Megalencephaly Capillary Malformation Polymicrogyria Syndrome was often described by its individual features or grouped with related overgrowth conditions.
Megalencephaly-Capillary Malformation-Polymicrogyria Syndrome (MCAP) is most commonly referred to by its acronym, MCAP, or as Megalencephaly-Capillary Malformation Syndrome. Due to its complex clinical presentation, it was historically categorized under various names before the genetic cause, specifically mutations in the PIK3CA gene, was identified.
Before the current, more precise nomenclature was adopted, Megalencephaly Capillary Malformation Polymicrogyria Syndrome was often described by its individual features or grouped with related overgrowth conditions. In older medical literature, you may encounter the following synonyms or related terms:
The variety of names for Megalencephaly Capillary Malformation Polymicrogyria Syndrome stems from the evolution of clinical diagnosis. Historically, doctors named the condition based on the distinct symptoms observed, such as the large brain size (megalencephaly) and skin vascular findings (capillary malformations). As medical research identified the PIK3CA gene as the underlying cause, the field moved toward the more descriptive MCAP designation. This reclassification helps differentiate it from other overgrowth syndromes, such as CLOVES syndrome, which shares a similar genetic pathway.
In international medical databases, Megalencephaly Capillary Malformation Polymicrogyria Syndrome is classified using specific identifiers to ensure consistency in research and clinical reporting:
Medical professionals currently prefer Megalencephaly Capillary Malformation Polymicrogyria Syndrome or the acronym MCAP. Using these terms will yield the most relevant results in current clinical literature and patient resources. Within the DiseaseMaps.org community, 23 people with Megalencephaly Capillary Malformation Polymicrogyria Syndrome have shared their experiences, providing a valuable network for those seeking support under this specific diagnosis.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult a qualified healthcare professional for diagnosis and treatment.